Germany· DE-A57-7437b806ad5de5e2
Calcort
A deflazacort product containing deflazacort, registered in Germany by Galenpharma Gmbh. The same ATC class is registered in 8 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Deflazacort is registered in 8 of 19 countries.
Countries holding a registration under ATC H02AB13 (deflazacort), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 3 of them publish a price we can compare per daily dose
Deflazacort · ATC H02AB13
8 / 19 countries
- Denmark
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deflazacort costs, country by country.
Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deflazacort · price per daily dose (15 mg)
USD · FX 28 Sept 2026
- ES Spain$0.19
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Deflazacort
- Manufacturer
- Galenpharma Gmbh
- Country
- Germany (DE)
- ATC code
- H02AB13
- ATC class
- Deflazacort
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for deflazacort.
Graded by severity as the source publishes them — 129 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deflazacort · interactions on record
434 records
- 129 severe
- 297 moderate
- 8 minor
Most severe, free to view
- AprepitantA04AD12severe
- LonafarnibA16AX20severe
- DesirudinB01AE01severe
- BerotralstatB06AC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deflazacort in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDeflazacortUpsher-Smith Laboratories, LLC
- SpainDEFAL 30 MG COMPRIMIDOS EFGFaes Farma S.A.
- United KingdomCalcort 1mg tabletsShire Pharmaceuticals Ltd
- SwedenDeflazacort XGX Pharma 30 mg TablettXGX Pharma ApS
- NetherlandsDeflazacort XGX Pharma 30 mg tablettenXGX Pharma ApS
- FinlandDeflazacort XGX PharmaXGX Pharma ApS
- NorwayCalcortGalen Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Denmark · Deflazacort Vital Pharma Nordic
- Spain · Defal, Deflazacort Cinfa
- Finland · Deflazacort Vital Pharma Nordic
- United Kingdom (Northern Ireland) · Calcort
- Italy · Decor, Deflan
- Netherlands · Deflazacort Xgx Pharma
- Norway · Deflazacort Xgx Pharma
- Portugal · Deflazacorte Acizan, Deflazacorte Almus
- Sweden · Deflazacort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1c42364-bf68-4cee-bf80-c1757fa70131 GET /v1/drugs/e1c42364-bf68-4cee-bf80-c1757fa70131?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Deflazacort",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about deflazacort.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.